Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Tissue distribution of SVT-40776 indicates a good safety profile

Sep. 29, 2005

AVE-7688 reduces renal fibrosis in COL4A3-/- mice

Sep. 26, 2005

Tachykinin antagonists prepared and tested at Takeda

Sep. 22, 2005

Calcium-sensing receptor (CaSR) validated as a target for bladder dysfunction

Sep. 16, 2005

BXL-628 demonstrates efficacy in experimental autoimmune prostatitis

Sep. 14, 2005

Sanctura XR enters phase III program for overactive bladder

Sep. 13, 2005

Update on darifenacin in overactive bladder

Sep. 12, 2005

Anturol begins phase II study for overactive bladder syndrome

Sep. 12, 2005

Webcasts from ICS Annual Meeting now available

Sep. 8, 2005

A phase II study supports the use of fesoterodine in overactive bladder

Sep. 8, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...